chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Visual impairment
Clinical narrative: Her eyesight was burning; Developed like ¨some ball of veins and swelling on the back of her left feet, of about 4 or 5 cm, that lasted 2 or 3 days; Cough; body aches; fever; Was tired; This spontaneous case was reported by a consumer and describes the occurrence of VISUAL IMPAIRMENT (Her eyesight was burning), VEIN DISORDER (Developed like ¨some ball of veins and swelling on the back of her left feet, of about 4 or 5 cm, that lasted 2 or 3 days), COUGH (Cough), MYALGIA (body aches) and PYREXIA (fever) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040AMA) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Mar-2021, the patient experienced VISUAL IMPAIRMENT (Her eyesight was burning), VEIN DISORDER (Developed like ¨some ball of veins and swelling on the back of her left feet, of about 4 or 5 cm, that lasted 2 or 3 days), COUGH (Cough), MYALGIA (body aches), PYREXIA (fever) and FATIGUE (Was tired). The patient was treated with NAPROXEN SODIUM (NAPROXEN [NAPROXEN SODIUM]) on 24-Mar-2021 at a dose of 500 mg. On 25-Mar-2021, VISUAL IMPAIRMENT (Her eyesight was burning), COUGH (Cough), MYALGIA (body aches), PYREXIA (fever) and FATIGUE (Was tired) outcome was unknown. At the time of the report, VEIN DISORDER (Developed like ¨some ball of veins and swelling on the back of her left feet, of about 4 or 5 cm, that lasted 2 or 3 days) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.    Patient concomitant medications was not reported.   Most recent FOLLOW-UP information incorporated above includes: On 20-Apr-2021: Follow-up information received on 20-APR-2021 HCP Information , patient details , Events were added .
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain in extremity
Clinical narrative: Arm pain; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm pain) and HEADACHE (Headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     Concurrent medical conditions included Type 2 diabetes mellitus. Concomitant products included DULOXETINE, BUPROPION, EMPAGLIFLOZIN (JARDIANCE), LISINOPRIL and EXENATIDE (BYDUREON) for an unknown indication.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, the patient experienced PAIN IN EXTREMITY (Arm pain) and HEADACHE (Headache). On 05-Mar-2021, PAIN IN EXTREMITY (Arm pain) and HEADACHE (Headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment information included Tylenol.   This case was linked to MOD-2021-081682 (E2B Linked Report).; Sender's Comments:  MOD-2021-081682:Dose2
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pruritus, Vaccination site erythema, Vaccination site pain, Vaccination site rash
Clinical narrative: Patient was given the vaccine, she felt the sting very strong; itching; big welt at the vaccination site; swollen; red  spot; inflamed; sore; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Patient was given the vaccine, she felt the sting very strong), PRURITUS (itching), VACCINATION SITE RASH (big welt at the vaccination site), VACCINATION SITE SWELLING (swollen) and VACCINATION SITE ERYTHEMA (red  spot) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046A21A and 042B21A.) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history reported.  Concomitant products included ASCORBIC ACID, CALCIUM CARBONATE (CALCIUM VITAMIN C [ASCORBIC ACID;CALCIUM CARBONATE]), ATORVASTATIN, fluxetine and VITAMIN D3 for an unknown indication.   On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. On 19-Apr-2021, the patient experienced VACCINATION SITE PAIN (Patient was given the vaccine, she felt the sting very strong), PRURITUS (itching), VACCINATION SITE RASH (big welt at the vaccination site), VACCINATION SITE SWELLING (swollen), VACCINATION SITE ERYTHEMA (red  spot), VACCINATION SITE PAIN (inflamed) and MYALGIA (sore). At the time of the report, VACCINATION SITE PAIN (Patient was given the vaccine, she felt the sting very strong), PRURITUS (itching), VACCINATION SITE RASH (big welt at the vaccination site), VACCINATION SITE SWELLING (swollen), VACCINATION SITE ERYTHEMA (red  spot), VACCINATION SITE PAIN (inflamed) and MYALGIA (sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Consent given. They preferred to be contacted by telephone.   This case was linked to MOD21-079205 (E2B Linked Report).; Sender's Comments:  MOD21-079205:husband
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: Patient was given the vaccine, she felt the sting very strong; itching; big welt at the vaccination site; swollen; red  spot; inflamed; sore; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Patient was given the vaccine, she felt the sting very strong), PRURITUS (itching), VACCINATION SITE RASH (big welt at the vaccination site), VACCINATION SITE SWELLING (swollen) and VACCINATION SITE ERYTHEMA (red  spot) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046A21A and 042B21A.) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history reported.  Concomitant products included ASCORBIC ACID, CALCIUM CARBONATE (CALCIUM VITAMIN C [ASCORBIC ACID;CALCIUM CARBONATE]), ATORVASTATIN, fluxetine and VITAMIN D3 for an unknown indication.   On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. On 19-Apr-2021, the patient experienced VACCINATION SITE PAIN (Patient was given the vaccine, she felt the sting very strong), PRURITUS (itching), VACCINATION SITE RASH (big welt at the vaccination site), VACCINATION SITE SWELLING (swollen), VACCINATION SITE ERYTHEMA (red  spot), VACCINATION SITE PAIN (inflamed) and MYALGIA (sore). At the time of the report, VACCINATION SITE PAIN (Patient was given the vaccine, she felt the sting very strong), PRURITUS (itching), VACCINATION SITE RASH (big welt at the vaccination site), VACCINATION SITE SWELLING (swollen), VACCINATION SITE ERYTHEMA (red  spot), VACCINATION SITE PAIN (inflamed) and MYALGIA (sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Consent given. They preferred to be contacted by telephone.   This case was linked to MOD21-079205 (E2B Linked Report).; Sender's Comments:  MOD21-079205:husband
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site swelling
Clinical narrative: Swelling kept growing and growing and right now it is a size of 5 inch; Redness at the injection site; Pain at the injection site; "severe swelling started by 1 inch" at the injection site; This spontaneous case was reported by a pharmacist and describes the occurrence of VACCINATION SITE ERYTHEMA (Redness at the injection site), VACCINATION SITE PAIN (Pain at the injection site), VACCINATION SITE SWELLING ("severe swelling started by 1 inch" at the injection site) and VACCINATION SITE SWELLING (Swelling kept growing and growing and right now it is a size of 5 inch) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Apr-2021, the patient experienced VACCINATION SITE ERYTHEMA (Redness at the injection site), VACCINATION SITE PAIN (Pain at the injection site) and VACCINATION SITE SWELLING ("severe swelling started by 1 inch" at the injection site). On an unknown date, the patient experienced VACCINATION SITE SWELLING (Swelling kept growing and growing and right now it is a size of 5 inch). At the time of the report, VACCINATION SITE ERYTHEMA (Redness at the injection site), VACCINATION SITE PAIN (Pain at the injection site) and VACCINATION SITE SWELLING (Swelling kept growing and growing and right now it is a size of 5 inch) outcome was unknown and VACCINATION SITE SWELLING ("severe swelling started by 1 inch" at the injection site) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Extra dose administered, Product storage error
Clinical narrative: Repetition of the second dose; second dose administered was not stored at a proper temperature; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT STORAGE ERROR (second Dose administered is not stored at a proper temperature) and EXTRA DOSE ADMINISTERED (Repetition of the second dose) in a 30-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included ALLOPURINOL for an unknown indication.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Apr-2021, the patient experienced PRODUCT STORAGE ERROR (second Dose administered is not stored at a proper temperature). On an unknown date, the patient experienced EXTRA DOSE ADMINISTERED (Repetition of the second dose). At the time of the report, PRODUCT STORAGE ERROR (second Dose administered is not stored at a proper temperature) and EXTRA DOSE ADMINISTERED (Repetition of the second dose) outcome was unknown. Unknown      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site swelling, Pain, Vaccination site erythema
Clinical narrative: soreness; Injection site was swollen in oblong shape like a welt; injection site was also red; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (soreness), INJECTION SITE SWELLING (Injection site was swollen in oblong shape like a welt) and VACCINATION SITE ERYTHEMA (injection site was also red) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Apr-2021, the patient experienced INJECTION SITE SWELLING (Injection site was swollen in oblong shape like a welt) and VACCINATION SITE ERYTHEMA (injection site was also red). On an unknown date, the patient experienced PAIN (soreness). At the time of the report, PAIN (soreness), INJECTION SITE SWELLING (Injection site was swollen in oblong shape like a welt) and VACCINATION SITE ERYTHEMA (injection site was also red) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.       Most recent FOLLOW-UP information incorporated above includes: On 27-May-2021: Events about the 2nd are added.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Feeling hot, Headache, Lymph node pain, Pain in extremity
Clinical narrative: arm is sore and tender again; itchy; hot to touch,hot; red in color about 2-3 inches in diameter; itchy rash; red rash; pain under arm; sore lymph node(which is still sore to date); headache; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache), PAIN IN EXTREMITY (sore arm), PAIN IN EXTREMITY (pain under arm), LYMPH NODE PAIN (sore lymph node(which is still sore to date)) and TENDERNESS (arm is sore and tender again) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Apr-2021, the patient experienced HEADACHE (headache) and PAIN IN EXTREMITY (sore arm). On 15-Apr-2021, the patient experienced PAIN IN EXTREMITY (pain under arm) and LYMPH NODE PAIN (sore lymph node(which is still sore to date)). On 21-Apr-2021, the patient experienced TENDERNESS (arm is sore and tender again), PRURITUS (itchy), FEELING HOT (hot to touch,hot), ERYTHEMA (red in color about 2-3 inches in diameter), RASH PRURITIC (itchy rash) and RASH ERYTHEMATOUS (red rash). On 30-Apr-2021, RASH PRURITIC (itchy rash) and RASH ERYTHEMATOUS (red rash) had resolved. At the time of the report, HEADACHE (headache), PAIN IN EXTREMITY (sore arm), PAIN IN EXTREMITY (pain under arm), LYMPH NODE PAIN (sore lymph node(which is still sore to date)), TENDERNESS (arm is sore and tender again), PRURITUS (itchy), FEELING HOT (hot to touch,hot) and ERYTHEMA (red in color about 2-3 inches in diameter) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-225207 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 16-Jun-2021: No specific follow-up information recorded.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash erythematous, Rash pruritic, Tenderness
Clinical narrative: arm is sore and tender again; itchy; hot to touch,hot; red in color about 2-3 inches in diameter; itchy rash; red rash; pain under arm; sore lymph node(which is still sore to date); headache; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache), PAIN IN EXTREMITY (sore arm), PAIN IN EXTREMITY (pain under arm), LYMPH NODE PAIN (sore lymph node(which is still sore to date)) and TENDERNESS (arm is sore and tender again) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Apr-2021, the patient experienced HEADACHE (headache) and PAIN IN EXTREMITY (sore arm). On 15-Apr-2021, the patient experienced PAIN IN EXTREMITY (pain under arm) and LYMPH NODE PAIN (sore lymph node(which is still sore to date)). On 21-Apr-2021, the patient experienced TENDERNESS (arm is sore and tender again), PRURITUS (itchy), FEELING HOT (hot to touch,hot), ERYTHEMA (red in color about 2-3 inches in diameter), RASH PRURITIC (itchy rash) and RASH ERYTHEMATOUS (red rash). On 30-Apr-2021, RASH PRURITIC (itchy rash) and RASH ERYTHEMATOUS (red rash) had resolved. At the time of the report, HEADACHE (headache), PAIN IN EXTREMITY (sore arm), PAIN IN EXTREMITY (pain under arm), LYMPH NODE PAIN (sore lymph node(which is still sore to date)), TENDERNESS (arm is sore and tender again), PRURITUS (itchy), FEELING HOT (hot to touch,hot) and ERYTHEMA (red in color about 2-3 inches in diameter) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-225207 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 16-Jun-2021: No specific follow-up information recorded.
Sex: F
Vaccine: COVID19
Symptoms: Adverse reaction
Clinical narrative: Other syptoms (not the ones listed on Patient's FAQs as signs of severe allergic reaction); This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (Other syptoms (not the ones listed on Patient's FAQs as signs of severe allergic reaction)) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE REACTION (Other syptoms (not the ones listed on Patient's FAQs as signs of severe allergic reaction)). At the time of the report, ADVERSE REACTION (Other syptoms (not the ones listed on Patient's FAQs as signs of severe allergic reaction)) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided. No treatment details pertained to the events were provided.   Reporter did not allow further contact
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Chills, Fatigue, Pain in extremity
Clinical narrative: Pain in chest; Arm hurt; Got tired; Chills; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (Pain in chest), PAIN IN EXTREMITY (Arm hurt), FATIGUE (Got tired) and CHILLS (Chills) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 02A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 21-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Apr-2021, the patient experienced CHEST PAIN (Pain in chest), PAIN IN EXTREMITY (Arm hurt), FATIGUE (Got tired) and CHILLS (Chills). At the time of the report, CHEST PAIN (Pain in chest), PAIN IN EXTREMITY (Arm hurt), FATIGUE (Got tired) and CHILLS (Chills) outcome was unknown.            Concomitant medication information was not reported. Treatment information as not reported. Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) is considered as not applicable.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster, Pruritus
Clinical narrative: painful shingles outbreak; Itching; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (painful shingles outbreak) and PRURITUS (Itching) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027B21A) for COVID-19 vaccination.     Concomitant products included LEVOTHYROXINE SODIUM (LEVOXYL) for an unknown indication.    On 11-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Apr-2021, the patient experienced HERPES ZOSTER (painful shingles outbreak) and PRURITUS (Itching). At the time of the report, HERPES ZOSTER (painful shingles outbreak) and PRURITUS (Itching) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant  medication use was not provided by the reporter. Treatment information was unknown.11April2021 patient received first vaccine dose of vaccine. Several hours after receiving their dose, the patient was on a bike ride and reports their back suddenly began to itch. Patient initially suspected a bug bite, but it later progressed to a painful shingles outbreak. Doctor confirmed diagnosis for patient on 16Apr2021 and she reports symptoms are still ongoing at the time of the call.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain in extremity
Clinical narrative: Patient is experiencing a sore arm; headaches; This spontaneous case was reported by a non-health professional and describes the occurrence of PAIN IN EXTREMITY (Patient is experiencing a sore arm) and HEADACHE (headaches) in a 19-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Apr-2021, the patient experienced PAIN IN EXTREMITY (Patient is experiencing a sore arm) and HEADACHE (headaches). At the time of the report, PAIN IN EXTREMITY (Patient is experiencing a sore arm) and HEADACHE (headaches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient received Tetanus vaccine and Moderna COVID-19 vaccine at same time.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Eating disorder, Pyrexia
Clinical narrative: she lost her sense of taste.; wasn't able to eat; high-grade fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (high-grade fever), AGEUSIA (she lost her sense of taste.) and EATING DISORDER (wasn't able to eat) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Apr-2021, the patient experienced PYREXIA (high-grade fever) and EATING DISORDER (wasn't able to eat). On 21-Apr-2021, the patient experienced AGEUSIA (she lost her sense of taste.). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN at an unspecified dose and frequency. On 21-Mar-2021, PYREXIA (high-grade fever) had resolved. On 21-Apr-2021, EATING DISORDER (wasn't able to eat) had resolved. At the time of the report, AGEUSIA (she lost her sense of taste.) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided.   This case was linked to MOD-2021-083321 (Patient Link).
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Gastrooesophageal reflux disease
Clinical narrative: Acid bath going down in her stomach; Stomach was upset and squishy; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (Stomach was upset and squishy) and GASTROOESOPHAGEAL REFLUX DISEASE (Acid bath going down in her stomach) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     The patient's past medical history included Surgery. Concurrent medical conditions included Allergy to grains.    On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Mar-2021, the patient experienced ABDOMINAL DISCOMFORT (Stomach was upset and squishy). On 30-Mar-2021, the patient experienced GASTROOESOPHAGEAL REFLUX DISEASE (Acid bath going down in her stomach). At the time of the report, ABDOMINAL DISCOMFORT (Stomach was upset and squishy) and GASTROOESOPHAGEAL REFLUX DISEASE (Acid bath going down in her stomach) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Gait disturbance, Pain, Pain in extremity, Vaccination site pain
Clinical narrative: has a hard time walking first thing in the morning; achiness in left leg and it's been over a month; pain is so bad; achiness in left hip and it's been over a month; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (has a hard time walking first thing in the morning), PAIN IN EXTREMITY (achiness in left leg and it's been over a month), PAIN (pain is so bad), ARTHRALGIA (achiness in left hip and it's been over a month) and VACCINATION SITE PAIN (sore arm) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032M20A and 015M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VACCINATION SITE PAIN (sore arm). On an unknown date, the patient experienced GAIT DISTURBANCE (has a hard time walking first thing in the morning), PAIN IN EXTREMITY (achiness in left leg and it's been over a month), PAIN (pain is so bad) and ARTHRALGIA (achiness in left hip and it's been over a month). The patient was treated with HYDROCODONE BITARTRATE, PARACETAMOL (VICODIN) at an unspecified dose and frequency. On 11-Mar-2021, VACCINATION SITE PAIN (sore arm) had resolved. At the time of the report, GAIT DISTURBANCE (has a hard time walking first thing in the morning), PAIN IN EXTREMITY (achiness in left leg and it's been over a month), PAIN (pain is so bad) and ARTHRALGIA (achiness in left hip and it's been over a month) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not provided. Action taken with the product mRNA_1273 is not Applicable.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Pyrexia, Trigger finger, Vaccination site scar
Clinical narrative: Fingers locked down; inflammation/swelling of fingers; Feeling feverish; Pin mark left in her right arm at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of TRIGGER FINGER (Fingers locked down), PERIPHERAL SWELLING (inflammation/swelling of fingers), VACCINATION SITE SCAR (Pin mark left in her right arm at the injection site) and PYREXIA (Feeling feverish) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013L20A and 011M20A) for COVID-19 vaccination.     No medical history was reported by the reporter.  Concomitant products included CARVEDILOL, LOSARTAN, HCTZ, Trulicity once a week, DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE (FARXIGA), GLIPIZIDE, LEVOTHYROXINE SODIUM (LEVOXYL), PRAVASTATIN, DULOXETINE HYDROCHLORIDE (CYMBALTA), OMEPRAZOLE and ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication. Treatment medication include Prednisone.   On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-Jan-2021, the patient experienced VACCINATION SITE SCAR (Pin mark left in her right arm at the injection site). On an unknown date, the patient experienced TRIGGER FINGER (Fingers locked down), PERIPHERAL SWELLING (inflammation/swelling of fingers) and PYREXIA (Feeling feverish). At the time of the report, TRIGGER FINGER (Fingers locked down), PERIPHERAL SWELLING (inflammation/swelling of fingers), VACCINATION SITE SCAR (Pin mark left in her right arm at the injection site) and PYREXIA (Feeling feverish) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment :Three separate rounds of a Prednisone Medrol pack.   This case was linked to MOD-2021-083617 (Patient Link).
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: headaches; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headaches) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Apr-2021, the patient experienced HEADACHE (headaches). The patient was treated with PARACETAMOL (TYLENOL) for Headache, at an unspecified dose and frequency. At the time of the report, HEADACHE (headaches) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medication was reported.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Discomfort, Pain, Pain in extremity
Clinical narrative: soreness on the arm; pain; discomfort; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (soreness on the arm), PAIN (pain) and DISCOMFORT (discomfort) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by reporter.  No concomitant medication reported.    On 21-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, the patient experienced PAIN (pain) and DISCOMFORT (discomfort). On an unknown date, the patient experienced PAIN IN EXTREMITY (soreness on the arm). At the time of the report, PAIN IN EXTREMITY (soreness on the arm), PAIN (pain) and DISCOMFORT (discomfort) outcome was unknown. Not Provided
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Headache, Influenza like illness, Myalgia, Sleep disorder
Clinical narrative: feels like she has the flu; woke up horribly; Muscle pain; joint pain; headache; arm hurt a little; This spontaneous case was reported by a physician and describes the occurrence of INFLUENZA LIKE ILLNESS (feels like she has the flu), SLEEP DISORDER (woke up horribly), VACCINATION SITE PAIN (arm hurt a little), MYALGIA (Muscle pain) and ARTHRALGIA (joint pain) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001B21A and 041B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by reporter.    Concomitant products included Centrum vitamins and CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) for an unknown indication.   On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Apr-2021, the patient experienced VACCINATION SITE PAIN (arm hurt a little). On 21-Apr-2021, the patient experienced INFLUENZA LIKE ILLNESS (feels like she has the flu), SLEEP DISORDER (woke up horribly), MYALGIA (Muscle pain), ARTHRALGIA (joint pain) and HEADACHE (headache). At the time of the report, INFLUENZA LIKE ILLNESS (feels like she has the flu), SLEEP DISORDER (woke up horribly), VACCINATION SITE PAIN (arm hurt a little), MYALGIA (Muscle pain), ARTHRALGIA (joint pain) and HEADACHE (headache) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: feels like she has the flu; woke up horribly; Muscle pain; joint pain; headache; arm hurt a little; This spontaneous case was reported by a physician and describes the occurrence of INFLUENZA LIKE ILLNESS (feels like she has the flu), SLEEP DISORDER (woke up horribly), VACCINATION SITE PAIN (arm hurt a little), MYALGIA (Muscle pain) and ARTHRALGIA (joint pain) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001B21A and 041B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by reporter.    Concomitant products included Centrum vitamins and CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) for an unknown indication.   On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Apr-2021, the patient experienced VACCINATION SITE PAIN (arm hurt a little). On 21-Apr-2021, the patient experienced INFLUENZA LIKE ILLNESS (feels like she has the flu), SLEEP DISORDER (woke up horribly), MYALGIA (Muscle pain), ARTHRALGIA (joint pain) and HEADACHE (headache). At the time of the report, INFLUENZA LIKE ILLNESS (feels like she has the flu), SLEEP DISORDER (woke up horribly), VACCINATION SITE PAIN (arm hurt a little), MYALGIA (Muscle pain), ARTHRALGIA (joint pain) and HEADACHE (headache) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Headache, Pain in extremity, Paraesthesia
Clinical narrative: a mild headache; some red spots on the tops of her hands; it's a little bit tingly; sore upper arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore upper arm), HEADACHE (a mild headache), ERYTHEMA (some red spots on the tops of her hands) and PARAESTHESIA (it's a little bit tingly) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by reporter.  No concomitant medication reported.     On 20-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2021, the patient experienced PAIN IN EXTREMITY (sore upper arm), ERYTHEMA (some red spots on the tops of her hands) and PARAESTHESIA (it's a little bit tingly). On 21-Apr-2021, the patient experienced HEADACHE (a mild headache). At the time of the report, PAIN IN EXTREMITY (sore upper arm), HEADACHE (a mild headache), ERYTHEMA (some red spots on the tops of her hands) and PARAESTHESIA (it's a little bit tingly) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       This case was linked to US-MODERNATX, INC.-MOD-2021-083707, US-MODERNATX, INC.-MOD-2021-083552 (Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: Added TCR-patient refuse further follow up; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-083707:Reporter(Caller) case US-MODERNATX, INC.-MOD-2021-083552:Caller Wife case
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Discomfort, Pain, Pain in extremity
Clinical narrative: soreness on the arm; pain; discomfort; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (pain), DISCOMFORT (discomfort) and PAIN IN EXTREMITY (soreness on the arm) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by reporter.  No concomitant medication reported.    On 21-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 21-Apr-2021, the patient experienced PAIN (pain) and DISCOMFORT (discomfort). On an unknown date, the patient experienced PAIN IN EXTREMITY (soreness on the arm). At the time of the report, PAIN (pain), DISCOMFORT (discomfort) and PAIN IN EXTREMITY (soreness on the arm) outcome was unknown. Not Provided       This case was linked to US-MODERNATX, INC.-MOD-2021-083927 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-083927:First dose
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Pain, Pain in extremity
Clinical narrative: Arm hurt; Felt like she was about to die; A lot of pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm hurt), FEELING ABNORMAL (Felt like she was about to die) and PAIN (A lot of pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by reporter.  No concomitant medication reported.     On 17-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm hurt), FEELING ABNORMAL (Felt like she was about to die) and PAIN (A lot of pain). At the time of the report, PAIN IN EXTREMITY (Arm hurt), FEELING ABNORMAL (Felt like she was about to die) and PAIN (A lot of pain) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Cough, Fatigue, Influenza like illness, Nasal congestion
Clinical narrative: flu-like symptoms; fever; chills; fatigue; body aches, pain; stuffy nose; weird cough; sore throat; pain; rash all over his chest; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash all over his chest), INFLUENZA LIKE ILLNESS (flu-like symptoms), PYREXIA (fever), CHILLS (chills) and FATIGUE (fatigue) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.      No Medical History information was reported. No concomitant medication reported.    On 17-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Apr-2021, the patient experienced RASH (rash all over his chest). On 18-Apr-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu-like symptoms), PYREXIA (fever), CHILLS (chills), FATIGUE (fatigue), PAIN (body aches, pain), NASAL CONGESTION (stuffy nose), COUGH (weird cough), OROPHARYNGEAL PAIN (sore throat) and PAIN (pain). At the time of the report, RASH (rash all over his chest), INFLUENZA LIKE ILLNESS (flu-like symptoms), PYREXIA (fever), CHILLS (chills), FATIGUE (fatigue), PAIN (body aches, pain), NASAL CONGESTION (stuffy nose), COUGH (weird cough), OROPHARYNGEAL PAIN (sore throat) and PAIN (pain) outcome was unknown. Not Provided
Sex: M
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Pain, Pyrexia, Rash
Clinical narrative: flu-like symptoms; fever; chills; fatigue; body aches, pain; stuffy nose; weird cough; sore throat; pain; rash all over his chest; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash all over his chest), INFLUENZA LIKE ILLNESS (flu-like symptoms), PYREXIA (fever), CHILLS (chills) and FATIGUE (fatigue) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.      No Medical History information was reported. No concomitant medication reported.    On 17-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Apr-2021, the patient experienced RASH (rash all over his chest). On 18-Apr-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu-like symptoms), PYREXIA (fever), CHILLS (chills), FATIGUE (fatigue), PAIN (body aches, pain), NASAL CONGESTION (stuffy nose), COUGH (weird cough), OROPHARYNGEAL PAIN (sore throat) and PAIN (pain). At the time of the report, RASH (rash all over his chest), INFLUENZA LIKE ILLNESS (flu-like symptoms), PYREXIA (fever), CHILLS (chills), FATIGUE (fatigue), PAIN (body aches, pain), NASAL CONGESTION (stuffy nose), COUGH (weird cough), OROPHARYNGEAL PAIN (sore throat) and PAIN (pain) outcome was unknown. Not Provided
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: redness; swelling of injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE ERYTHEMA (redness) and INJECTION SITE SWELLING (swelling of injection site) in a 23-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030A21A and 021B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. On 15-Mar-2021, the patient experienced INJECTION SITE ERYTHEMA (redness) and INJECTION SITE SWELLING (swelling of injection site). At the time of the report, INJECTION SITE ERYTHEMA (redness) and INJECTION SITE SWELLING (swelling of injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       other con medications: including birth control. When the caller ask the vaccine administrator regarding the issue, he assured the patient that another dose of the vaccine wouldn't be necessary.   This case was linked to MOD-2021-074360 (Linked Report).; Sender's Comments:  MOD-2021-074360:Second Dose Case
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Product availability issue, Product dose omission issue
Clinical narrative: been trying to get the second dose and no one will give it because they only have Pfize; missed second dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT AVAILABILITY ISSUE (been trying to get the second dose and no one will give it because they only have Pfize) and PRODUCT DOSE OMISSION ISSUE (missed second dose) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT AVAILABILITY ISSUE (been trying to get the second dose and no one will give it because they only have Pfize) and PRODUCT DOSE OMISSION ISSUE (missed second dose). At the time of the report, PRODUCT AVAILABILITY ISSUE (been trying to get the second dose and no one will give it because they only have Pfize) and PRODUCT DOSE OMISSION ISSUE (missed second dose) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medication was reported.  Treatment information was not provided.Patient received the first dose of the Moderna COVID-19 vaccine on 08Jan2021 on the left arm. She missed her second dose appointment since she was out of town. The vaccination facility does not have Moderna in stock. She stated she has been trying to get the second dose and no one will give it to her because she is trying to get Pfizer vaccine since she cannot find a location that has Moderna COVID-19 vaccine in stock.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dyspnoea, Headache, Heart rate increased, Pharyngeal swelling
Clinical narrative: chills; headache; swelling of the throat; shortness of breath; fast heartbeat; This spontaneous case was reported by a non-health professional and describes the occurrence of PHARYNGEAL SWELLING (swelling of the throat), DYSPNOEA (shortness of breath), HEART RATE INCREASED (fast heartbeat), CHILLS (chills) and HEADACHE (headache) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 20-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Apr-2021, the patient experienced PHARYNGEAL SWELLING (swelling of the throat), DYSPNOEA (shortness of breath), HEART RATE INCREASED (fast heartbeat), CHILLS (chills) and HEADACHE (headache). At the time of the report, DYSPNOEA (shortness of breath), HEART RATE INCREASED (fast heartbeat) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-085455 (Patient Link).
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Nausea, Pain, Pain in extremity
Clinical narrative: body aches; arm is so painful; diarrhea little bit.; chills; fever of 99 degree; nausea; throwing up; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (body aches), PAIN IN EXTREMITY (arm is so painful), DIARRHOEA (diarrhea little bit.), CHILLS (chills) and PYREXIA (fever of 99 degree) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, the patient experienced PAIN (body aches), PAIN IN EXTREMITY (arm is so painful), DIARRHOEA (diarrhea little bit.), CHILLS (chills), PYREXIA (fever of 99 degree), NAUSEA (nausea) and VOMITING (throwing up). At the time of the report, PAIN (body aches), PAIN IN EXTREMITY (arm is so painful), DIARRHOEA (diarrhea little bit.), CHILLS (chills), PYREXIA (fever of 99 degree), NAUSEA (nausea) and VOMITING (throwing up) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 21-Apr-2021, Pyrexia: 99 (Inconclusive) patient reports fever.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  Patient asked whether she can take Tylenol and Advil for her body aches.   Reporter did not allow further contact